The life of Fountain Fountain Life of Tony Robbins and Peter Diamandis, the Longevity Company, collects $ 18 million

Eight years ago, the orthopedic surgeon, Dr. William Kapp, attended a medical conference that changed his professional life.

He had gone from a private doctor to co-found a business that built intensive care hospitals to sell this business. This gave him an interest in both sides of health care: medicine and business sides, he told Techcrunch.

He therefore went to the annual conference organized by the famous doctor-scientist, Dr. Daniel Kraft, to find out more about new technologies that could improve results while reducing costs. Dr. Peter Diamandis, founder and president of the Xprize Foundation, was on stage that year with Dr. Bob Hariri, pioneer in STEM cells and co-founder of several health technicians such as the genomics Human Longevity, said Kapp. They discussed genomics, microbiomics and new technology that was not part of consumer medicine.

Inspired, Kapp returned to his hometown of Naples, Florida, and “started something called Longevity Performance Center. The idea was to do early detection and then an optimization of people’s health,” he said.

In March 2020, Diamandis (photo above) and her boyfriend Tony Robbins heard of the center of Kapp and visited. They had a stem cell startup called Fountain Therapeutics. The conversation quickly turned to a merger and in October of the same year, the two companies became Fountain.

KAPP remained CEO with Diamandis and Robbins as co-founders and members of the board of directors.

Today, its board of directors also includes Hariri as an advisor; Todd Wanek, CEO of Ashley Furniture Industries, as an investor; And the rich magnate of the Indian company BK Modi as an investor.

Fountain Life says exclusively to Techcrunch that he has just raised a B series of $ 18 million, led by Eos Ventures, with the participation of most of the existing members of the Board of Directors. Fountain previously raised a series A of $ 80 million and has raised around $ 108 million in total, said KAPP.

Longevity as a subject of a serious study by the medical community is a new field. When Kapp (photo below) launched its center for the first time, “we did not know exactly what longevity meant,” he said. But in the past four or five years, much more research has been carried out.

The first principle of longevity, he said, is “does not die anything stupid”. Consequently, the centers of the life of Fountain, four of which are focusing on prevention screening, looking for diseases and chronic conditions at the start when they tend to be asymptomatic. Blood tests and bodily analyzes collect data on more than 100 biomarkers, liver fat to “microbiome concentrations,” he said.

The second director is optimization, which means improving these markers with scientifically validated treatments, he said. And the third director is “to use the latest regenerative therapies as part of FDA tests”, to treat the disease or obtain optimization.

Screen tests can discover, for example, intestinal bacterial proliferation (SIBO), which, untreated, can lead to certain cancers, he said. The solution, if taken early, consists in restoring the balance of microbiomas with specific and prescribed microbiotics.

For Fountain members, the tests are repeated every quarter approximately, and patients can follow the results and ask questions to an application fueled by the AI called Zori.

But it’s expensive, admitted Kapp. A full subscription costs $ 30,000 per year, and $ 10,000 will only cover the test process and AI, but not current tests and medical support.

However, Kapp remembers two stories that told him that this work was on the right track. The wife of a Robbins fan bought her husband a subscription, and the tests have successfully reinforced asymptomatic kidney cancer. The husband is now without cancer.

When the World Hotelman Sam Nazarian explored a partnership with Fountain Put longevity centers in luxury hotelsNazarian did Fountain tests and found a cerebral aneurysm. They treated it successfully, Nazarian has said publicly.

KAPP claims that new funding will allow the company to open more centers. In addition to Naples, they opened installations in Orlando, Dallas and Westchester, New York; A Houston center will open in December. The centers of Los Angeles and Miami are scheduled for the first quarter of 2026.

He hopes to solve the problem of affordability by working on the “development of the clinic” where Fountain trains medical facilities on his methodologies. KAPP says that technology and expertise become more widely available, this will lower access costs.

The fountain is not the only longevity testing startup focused on the doctor. The famous functional health doctor Mark Hyman has a company called Functional health. It offers a set of around 160 blood tests, with follow -up tests every three to six months, for a subscription of $ 500 / year (with additional costs for additional blood tests). Its platform analyzes and also follows the test results, although it does not make full bodily digitalizations or does not offer direct access to doctors.

We always seek to evolve, and by providing an overview of your point of view and your comments on Techcrunch and our coverage and our events, you can help us! Fill This investigation To let us know how we make and have the chance to win a price in return!